Evidence map›Paper›PMID 35075100›Full record

ArticleMedical science monitor : international medical journal of experimental and clinical research2022

Virtual Screening and Molecular Docking to Study the Mechanism of Chinese Medicines in the Treatment of Coronavirus Infection.

Fan Ping, Yanxia Wang, Xia Shen, Conge Tan, Lin Zhu, Wenwen Xing, Jun Xu

Open access · hybridAbstract read
In one paragraph

Article in Medical science monitor : international medical journal of experimental and clinical research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Fan PingCollege of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, China (mainland).
Yanxia WangCollege of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, China (mainland).
Xia ShenCollege of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, China (mainland).
Conge TanCollege of Basic Medicine, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, China (mainland).
Lin ZhuCollege of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, China (mainland).
Wenwen XingCollege of Basic Medicine, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, China (mainland).
Jun XuChinese Medicine Research and Development Center, Tianjin Institute of Pharmaceutical Research, Tianjin, China (mainland).
Shaanxi University of Chinese Medicine · CNTianjin Institute of Pharmaceutical Research (China) · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Heat-clearing and detoxifying herbs (HDHs) play an important role in the prevention and treatment of coronavirus infection. However, their mechanism of action needs further study. This study aimed to explore the anti-coronavirus basis and mechanism of HDHs. MATERIAL AND METHODS Database mining was performed on 7 HDHs. Core ingredients and targets were screened according to ADME rules combined with Neighborhood, Co-occurrence, Co-expression, and other algorithms. GO enrichment and KEGG pathway analyses were performed using the R language. Finally, high-throughput molecular docking was used for verification. RESULTS HDHs mainly acts on NOS3, EGFR, IL-6, MAPK8, PTGS2, MAPK14, NFKB1, and CASP3 through quercetin, luteolin, wogonin, indirubin alkaloids, ß-sitosterol, and isolariciresinol. These targets are mainly involved in the regulation of biological processes such as inflammation, activation of MAPK activity, and positive regulation of NF-kappaB transcription factor activity. Pathway analysis further revealed that the pathways regulated by these targets mainly include: signaling pathways related to viral and bacterial infections such as tuberculosis, influenza A, Ras signaling pathways; inflammation-related pathways such as the TLR, TNF, MAPK, and HIF-1 signaling pathways; and immune-related pathways such as NOD receptor signaling pathways. These pathways play a synergistic role in inhibiting lung inflammation and regulating immunity and antiviral activity. CONCLUSIONS HDHs play a role in the treatment of coronavirus infection by regulating the body's immunity, fighting inflammation, and antiviral activities, suggesting a molecular basis and new strategies for the treatment of COVID-19 and a foundation for the screening of new antiviral drugs.

Indexed as

COVID-19 Drug TreatmentAlkaloidsCaspase 3CoronavirusCoronavirus InfectionsCyclooxygenase 2Databases, PharmaceuticalDrugs, Chinese HerbalFlavanonesHumansIndolesInterleukin-6LigninLuteolinMitogen-Activated Protein Kinase 14Mitogen-Activated Protein Kinase 8AlkaloidsCaspase 3Cyclooxygenase 2Drugs, Chinese HerbalFlavanonesgamma-sitosterolindirubinIndolesInterleukin-6isolariciresinolLigninLuteolinMitogen-Activated Protein Kinase 14Mitogen-Activated Protein Kinase 8NaphtholsNF-kappa B p50 SubunitNitric Oxide Synthase Type IIIQuercetinSitosterolswogonin

Identifiers

PMID35075100
PMCPMC8800284
OpenAlexW3214493780

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.